These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14585761)

  • 1. Effects of the hepatic lipase gene and physical activity on coronary heart disease risk.
    Hokanson JE; Kamboh MI; Scarboro S; Eckel RH; Hamman RF
    Am J Epidemiol; 2003 Nov; 158(9):836-43. PubMed ID: 14585761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.
    Hokanson JE; Cheng S; Snell-Bergeon JK; Fijal BA; Grow MA; Hung C; Erlich HA; Ehrlich J; Eckel RH; Rewers M
    Diabetes; 2002 Apr; 51(4):1208-13. PubMed ID: 11916946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity.
    Zhang C; Lopez-Ridaura R; Rimm EB; Li T; Hunter DJ; Hu FB
    Diabetologia; 2006 Jul; 49(7):1552-9. PubMed ID: 16570154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the effect of hepatic lipase gene polymorphism on the risk of coronary heart disease.
    Wang H; Jiang M; Qiu J
    Arch Med Res; 2010 Jul; 41(5):383-90. PubMed ID: 20851298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the --514 C-->T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis.
    Faggin E; Zambon A; Puato M; Deeb SS; Bertocco S; Sartore S; Crepaldi G; Pessina AC; Pauletto P
    J Am Coll Cardiol; 2002 Sep; 40(6):1059-66. PubMed ID: 12354428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study.
    Zito F; Lowe GD; Rumley A; McMahon AD; Humphries SE;
    Atherosclerosis; 2002 Nov; 165(1):153-8. PubMed ID: 12208481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Zacharova J; Todorova BR; Chiasson JL; Laakso M;
    J Intern Med; 2005 Feb; 257(2):185-93. PubMed ID: 15656877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease.
    Hong SH; Song J; Kim JQ
    Clin Biochem; 2000 Jun; 33(4):291-6. PubMed ID: 10936588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.
    Ledmyr H; McMahon AD; Ehrenborg E; Nielsen LB; Neville M; Lithell H; MacFarlane PW; Packard CJ; Karpe F;
    Circulation; 2004 May; 109(19):2279-84. PubMed ID: 15136504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
    Shohet RV; Vega GL; Anwar A; Cigarroa JE; Grundy SM; Cohen JC
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1975-8. PubMed ID: 10446080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese.
    Tan KC; Shiu SW; Chu BY
    Atherosclerosis; 2001 Jul; 157(1):233-9. PubMed ID: 11427226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy.
    Zambon A; Deeb SS; Pauletto P; Crepaldi G; Brunzell JD
    Curr Opin Lipidol; 2003 Apr; 14(2):179-89. PubMed ID: 12642787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.
    Tahvanainen E; Syvanne M; Frick MH; Murtomaki-Repo S; Antikainen M; Kesaniemi YA; Kauma H; Pasternak A; Taskinen MR; Ehnholm C
    J Clin Invest; 1998 Mar; 101(5):956-60. PubMed ID: 9486964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.